- Home
- PHVS vs ADEA Comparison
PHVS vs ADEA Comparison
Compare PHVS & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- ADEA
- Stock Information
- Founded
- PHVS 2015
- ADEA 1990
- Country
- PHVS Switzerland
- ADEA United States
- Employees
- PHVS N/A
- ADEA N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- ADEA Computer Software: Prepackaged Software
- Sector
- PHVS Health Care
- ADEA Technology
- Exchange
- PHVS Nasdaq
- ADEA Nasdaq
- Market Cap
- PHVS 1.6B
- ADEA 1.5B
- IPO Year
- PHVS 2021
- ADEA N/A
- Fundamental
- Price
- PHVS $24.95
- ADEA $12.46
- Analyst Decision
- PHVS Buy
- ADEA Strong Buy
- Analyst Count
- PHVS 7
- ADEA 4
- Target Price
- PHVS $37.00
- ADEA $19.50
- AVG Volume (30 Days)
- PHVS 282.9K
- ADEA 1.0M
- Earning Date
- PHVS 11-12-2025
- ADEA 11-03-2025
- Dividend Yield
- PHVS N/A
- ADEA 1.61%
- EPS Growth
- PHVS N/A
- ADEA 75.65
- EPS
- PHVS N/A
- ADEA 0.65
- Revenue
- PHVS N/A
- ADEA $379,912,000.00
- Revenue This Year
- PHVS N/A
- ADEA $9.49
- Revenue Next Year
- PHVS N/A
- ADEA $4.94
- P/E Ratio
- PHVS N/A
- ADEA $19.13
- Revenue Growth
- PHVS N/A
- ADEA 10.53
- 52 Week Low
- PHVS $11.51
- ADEA $10.59
- 52 Week High
- PHVS $26.33
- ADEA $18.25
- Technical
- Relative Strength Index (RSI)
- PHVS 57.14
- ADEA 33.65
- Support Level
- PHVS $23.76
- ADEA $11.61
- Resistance Level
- PHVS $26.20
- ADEA $14.33
- Average True Range (ATR)
- PHVS 1.77
- ADEA 0.52
- MACD
- PHVS 0.19
- ADEA -0.09
- Stochastic Oscillator
- PHVS 75.19
- ADEA 25.00
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.